Medical Marijuana Inc.’s HempMeds Makes Global News Headlines and Report Issued by Top Laboratory

Support of HempMeds and Cannabidiol (CBD)-Rich Hemp Oil Products Expands to Mainstream Media, Medical Professionals and Natural Health Advocates

SAN DIEGO, June 12, 2014 (GLOBE NEWSWIRE) — Medical Marijuana, Inc. (OTC Pink:MJNA) is excited to announce that its subsidiary HempMeds™ and the cannabidiol (CBD)-rich hemp oil that the company represents, markets and distributes are making positive news headlines around the world after participating in the Chicago Cannabis Conference hosted by, a 501(c)3 non-profit organization. These innovative CBD-rich hemp oil products have been reviewed by top laboratories in the cannabis industry. The latest test results and certificates of analysis (COA) can be found at:

“HempMeds™ is extremely proud to offer multi-award winning CBD-rich hemp oil products that our customers trust and rely on,” states Andrew Hard, Director of Public Relations for HempMeds™. “From ‘seed to sale,’ the Company conducts multiple internal analyses to comply with multi-national government agencies in order to import our hemp oil. Once imported, the CBD-rich hemp oil undergoes further internal testing and at least one third-party analysis per batch prior to creating retail products. As news about these innovative CBD-rich hemp oil nutritional supplements, functional foods, and personal care products spreads globally, we felt that sharing these extremely detailed laboratory reports will show the public the great care taken to ensure our customers always receive an exceptionally high quality product with each purchase. We clearly go the extra mile to gain and retain our customers’ trust.”

Hard continues, “In addition to the support we receive from our customers, we are equally thrilled that members of the medical community, healthcare practitioners, parents, individuals, and the mainstream news media are supporting the CBD-rich hemp oil brands that HempMeds provides.”

To see what these professionals are saying about HempMeds click here:

At the Chicago Cannabis Conference hosted by, word about the CBD-rich hemp oil products that HempMeds™ represents spread virally from Chicago to global news outlets via an AFP report. Images from the conference are available via Getty Images. Other media outlets that featured HempMeds™ at the Chicago Cannabis Conference include: NBC, FOX News, CBS 2, USA Today, The Chicago Sun-Times, The Chicago Tribune, WGN-TV, WBBM-780/105.9 FM, WGN AM 720, MSN, WHDT World News/Next News Network, the Robert Scott Bell Show airing on Natural News Network, and AutismOne’s A Conversation of Hope airing on VoiceAmerica.

Hard concludes, “We are experiencing a global trend of consumers actively searching for all-natural CBD-rich hemp oil products. We are grateful that they are looking to HempMeds™ and recommending HempMeds™ as a go-to option in all 50 states and more than 40 countries.”

Interested parties who would like to discuss the findings with the laboratories that conducted detailed analysis are welcome to contact:

Stewart Environmental Consultants, LLC
3801 Automation Way, Suite 200 Fort Collins, Colorado 80525
970.226.5500 / 800.373.1348 (O) / 970.226.4946 (F)

About HempMeds

HempMeds offers mainstream marketing, sales, customer service, and logistics for the cannabis industry. HempMeds is a corporate portfolio company of Medical Marijuana, Inc. (OTC Pink:MJNA) and the exclusive master distributor for Medical Marijuana Inc. In addition to handling sales and distribution, HempMeds is the communication hub for the Medical Marijuana Inc. portfolio of companies.

About Medical Marijuana Inc.

Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For more information, please visit the company’s website at:


These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.


This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana Inc. to be materially different from the statements made herein.


Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The Company does grow, sell, and distribute hemp-based products and is involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.

Andrew Hard
Director of Public Relations, HempMeds
P. 858-335-6563